Abstract
Recently, the interest for brachytherapy in prostate cancer increased due to the fact that about four out of five prostate cancers are found in an early stage and to the development of new technologies for improving seeds implant. Moreover, the new technologies have significantly improved treatment accuracy, efficiency and outcomes in brachytherapy. Here, we will discuss the recent acquisitions in terms of technologies, instrumentations and procedures in brachytherapy. Moreover, the oncological, functional and quality of life-related results will be discussed, with attention on the lack of randomised clinical trials. However, based on the analysis of all reported experiences, the European Association of Urology suggested that the use of brachytherapy should be limited to patients with cT1-T2a, Gleason score <7 (or 3 + 4), PSA <10 ng/mL, prostate volume <50 mL, without a previous TURP and with a good IPSS.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
U.S. Cancer Statistics Working Group (2010) United States Cancer Statistics: 1999–2006 incidence and mortality web-based report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, 2010
Welch HG, Albertsen PC (2009) Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Natl Cancer Inst 101(19):1325–1329
Jani AB, Johnstone PAS, Liauw SL, Master VA, Brawley OW (2008) Age and grade trends in prostate cancer (1974–2003): a surveillance, epidemiology, and end results registry analysis. Am J Clin Oncol 31(4):375–378
European Association of Urology (EAU) guidelines on prostate cancer – http://uroweb.org/wp-content/uploads/1607-Prostate-Cancer_LRV3.pdf
Godtman RA, Holmberg E, Khatami A et al (2013) Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial. Eur Urol 63(1):101–107
Zhou J, Zamdborg L, Sebastian E (2015) Review of advanced catheter technologies in radiation oncology brachytherapy procedures. Cancer Manag Res 7:199–211
Holm HH, Juul N, Pedersen JF et al (1983) Transperineal seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130(2):283–286
Ash D, Flynn A, Batterman J et al; ESTRO/EAU Urological Brachytherapy Group; EORTC Radiotherapy Group (2000) ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57(3):315–321
Bharat S, Kung C, Dehghan E, Ravi A, Venugopal N, Bonillas A, Stanton D, Kruecker J (2014) Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate. Brachytherapy 13(6):640–650
Langley SE, Laing RW (2012) 4D Brachytherapy, a novel real-time prostate brachytherapy technique using stranded and loose seeds. BJU Int 109(Suppl 1):1–6
Budäus L, Bolla M, Bossi A et al (2012) Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol 61(1):112–127
Chen AB, D’Amico AV, Neville BA et al (2006) Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol 24(33):5298–5304
Machtens S, Baumann R, Hagemann J et al (2006) Long-term results of interstitial brachytherapy (LDR brachytherapy) in the treatment of patients with prostate cancer. World J Urol 24(3):289–295
Grimm PD, Blasko JC, Sylvester JE et al (2001) 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 51(1):31–40
Potters L, Morgenstern C, Calugaru E et al (2008) 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 179(5 Suppl):S20–S24
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Cai, T. (2017). Ultrasound-Guided Treatment of Prostatic Cancer: Brachytherapy. In: Martino, P., Galosi, A. (eds) Atlas of Ultrasonography in Urology, Andrology, and Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-40782-1_33
Download citation
DOI: https://doi.org/10.1007/978-3-319-40782-1_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40780-7
Online ISBN: 978-3-319-40782-1
eBook Packages: MedicineMedicine (R0)